Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage

Arthritis Research and Therapy

Volumn 14, Issue 3, 2012, Pages

  Dejica, Valeria M ^a   Mort, John S ^a,b   Laverty, Sheila ^c   Antoniou, John ^d   Zukor, David J ^d   Tanzer, Michael ^e   Poole, A Robin ^b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; COLLAGEN TYPE 2; COLLAGENASE; EPITOPE;

ADULT; AGED; AGING; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; DEGENERATION; ENZYME ACTIVITY; FEMUR CONDYLE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; OSTEOARTHRITIS; PROTEIN DEGRADATION; CADAVER; FEMALE; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGING; CADAVER; CARTILAGE, ARTICULAR; CATHEPSIN K; COLLAGEN TYPE II; COLLAGENASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OSTEOARTHRITIS; YOUNG ADULT;

EID: 84860802481     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3839     Document Type: Article

References (35)

1. Lane JM, Weiss C. Review of articular cartilage collagen research. Arthritis Rheum 1975, 18:553-562. 10.1002/art.1780180605, 173345.
2. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, Chen J, Van Wart H, Poole AR. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997, 99:1534-1545. 10.1172/JCI119316, 507973, 9119997.
3. Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J, Liljeström M, Hukkanen M, Takagi M, Virtanen I, Santavirta S. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 2002, 46:953-960. 10.1002/art.10185, 11953972.
4. Dejica VM, Mort JS, Laverty S, Percival MD, Antoniou J, Zukor DJ, Poole AR. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. Am J Pathol 2008, 173:161-169. 10.2353/ajpath.2008.070494, 2438294, 18511517.
5. Connor JR, LePage C, Swift BA, Yamashita D, Bendele AM, Maul D, Kumar S. Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis. Osteoarthritis Cartilage 2009, 17:1236-1243. 10.1016/j.joca.2009.03.015, 19361586.
6. Kozawa E, Nishida Y, Cheng XW, Urakawa H, Arai E, Futamura N, Shi GP, Kuzuya M, Hu L, Sasaki T, Ishiguro N. Osteoarthritic change is delayed in a cathepsin K knockout mouse model of osteoarthritis. Arthritis Rheum 2012, 64:454-464. 10.1002/art.33398, 21968827.
7. Svelander L, Erlandsson-Harris H, Astner L, Grabowska U, Klareskog L, Lindstrom E, Hewitt E. Inhibition of cathepsin K reduces bone erosion, cartilage degradation and inflammation evoked by collagen-induced arthritis in mice. Eur J Pharmacol 2009, 613:155-162. 10.1016/j.ejphar.2009.03.074, 19358841.
8. Kafienah W, Brömme D, Buttle DJ, Croucher LJ, Hollander AP. Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 1998, 331:727-732. 1219411, 9560298.
9. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, Foged NT, Delmas PD, Delaissé JM. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352. 10.1074/jbc.273.48.32347, 9822715.
10. Kempson GE, Muir H, Pollard C, Tuke M. The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans. Biochim Biophys Acta 1973, 297:456-472. 10.1016/0304-4165(73)90093-7, 4267503.
11. Bank RA, Soudry M, Maroudas A, Mizrahi J, TeKoppele JM. The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation. Arthritis Rheum 2000, 43:2202-2210. 10.1002/1529-0131(200010)43:10<2202::AID-ANR7>3.0.CO;2-E, 11037879.
12. Miller EJ, Harris ED, Chung E, Finch JE, McCroskery PA, Butler WT. Cleavage of Type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens. Biochemistry 1976, 15:787-792. 10.1021/bi00649a009, 174719.
13. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049. 10.1002/art.1780290816, 3741515.
14. Poole AR, Ionescu M, Fitzcharles MA, Billinghurst RC. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 2004, 294:145-153. 10.1016/j.jim.2004.09.005, 15637808.
15. Miosge N, Hartmann M, Maelicke C, Herken R. Expression of collagen type I and type II in consecutive stages of human osteoarthritis. Histochem Cell Biol 2004, 122:229-236. 10.1007/s00418-004-0697-6, 15316793.
16. Aigner T, Bertling W, Stöss H, Weseloh G, von der Mark K. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 1993, 91:829-837. 10.1172/JCI116303, 288034, 7680669.
17. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995, 96:2859-2869. 10.1172/JCI118357, 185997, 8675657.
18. Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, Poole AR. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 2002, 46:2087-2094. 10.1002/art.10428, 12209513.
19. Gallyas F, Merchenthaler I. Copper-H2O2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction. J Histochem Cytochem 1988, 36:807-810. 10.1177/36.7.2898497, 2898497.
20. Loeser RF. Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 2010, 26:371-386. 10.1016/j.cger.2010.03.002, 2920876, 20699160.
21. Buckwalter JA, Roughley PJ, Rosenberg LC. Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies. Microsc Res Tech 1994, 28:398-408. 10.1002/jemt.1070280506, 7919527.
22. Aurich M, Mwale F, Reiner A, Mollenhauer JA, Anders JO, Fuhrmann RA, Kuettner KE, Poole AR, Cole AA. Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface. Arthritis Rheum 2006, 54:244-252. 10.1002/art.21535, 16388531.
23. Leong DJ, Sun HB. Events in articular chondrocytes with aging. Curr Osteoporos Rep 2011, 9:196-201. 10.1007/s11914-011-0070-3, 21912847.
24. Poole AR, Guilak F, Abramson SB. Etiopathogenesis of osteoarthritis. Osteoarthritis, Diagnosis and Medical/Surgical Management 2007, 27-49. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins, Moskowitz RW, Altman RD, Hochberg MC, Buckwalter JA, Goldberg VM, 4.
25. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135. 10.1002/art.20776, 15641080.
26. Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000, 2:459-465. 10.1007/s11926-000-0021-y, 11123098.
27. Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, Reiner A, Tanzer M, Zukor D, Chen J, van Wart HE, Poole AR. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000, 43:673-682. 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8, 10728762.
28. Hou WS, Li Z, Büttner FH, Bartnik E, Brömme D. Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem 2003, 384:891-897.
29. Vinardell T, Dejica V, Poole AR, Mort JS, Richard H, Laverty S. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis. Osteoarthritis Cartilage 2009, 17:375-383. 10.1016/j.joca.2008.07.017, 18809344.
30. Degroot J, Verzijl N, Wenting-van Wijk MJ, Bank RA, Lafeber FP, Bijlsma JW, TeKoppele JM. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products. Arthritis Rheum 2001, 44:2562-2571. 10.1002/1529-0131(200111)44:11<2562::AID-ART437>3.0.CO;2-1, 11710713.
31. Degroot J, Verzijl N, Jacobs KM, Budde M, Bank RA, Bijlsma JW, TeKoppele JM, Lafeber FP. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage 2001, 9:720-726. 10.1053/joca.2001.0469, 11795991.
32. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, Rosenquist C, Qvist P. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001, 29:209-215. 10.1016/S8756-3282(01)00504-X, 11557363.
33. Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003, 48:3130-3139. 10.1002/art.11326, 14613275.
34. Charni N, Juillet F, Garnero P. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2005, 52:1081-1090. 10.1002/art.20930, 15818703.
35. Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, Karsdal MA, Duffin KL. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum 2008, 58:2420-2431. 10.1002/art.23654, 18668564.